Non-brokered financing comprised of 11 million units sold at C$0.29
By Devika Patel
Knoxville, Tenn., April 26 - Diagnos Inc. said it plans a C$3.19 million non-brokered private placement of units.
The company will sell 11 million units at C$0.29 apiece. Each unit consists of one common share and one half-share warrant, with each whole warrant exercisable at C$0.40 for 18 months.
The strike price is a 35.59% premium to the April 25 closing share price of C$0.295.
Based in Brossard, Quebec, Diagnos develops data-mining software used in the fields of healthcare, natural resources and entertainment.
| Issuer: | Diagnos Inc.
|
| Issue: | Units of one common share and one half-share warrant
|
| Amount: | C$3.19 million
|
| Units: | 11 million
|
| Price: | C$0.29
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | 18 months
|
| Warrant strike price: | C$0.40
|
| Agent: | Non-brokered
|
| Pricing date: | April 26
|
| Stock symbol: | TSX Venture: ADK
|
| Stock price: | C$0.295 at close April 25
|
| Market capitalization: | C$14.38 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
